|
Fig. 7 The stacked column chart illustrates the percentage of developing embryos with isolated and multiple neural tube defects at 120 hpf in groups exposed to decitabine alone and in presence of myo-inositol (n=20). The percentage of phenotypic outcomes with isolated neural tube defect in group exposed to DCT 1 mM was 5% and multiple neural tube defect was 95% with 100% incidence of neural tube defects, whereas in group exposed to DCT 1 mM + MI 50 µM, the percentage of phenotypic outcomes with isolated neural tube defect was 15% and the percentage of phenotypic outcomes with multiple neural tube defect was 50%. The remaining 35% were found normal. In group exposed to DCT 1 mM + MI 100 µM, the percentage of phenotypic outcomes with isolated neural tube defect was 15%, and the percentage of phenotypic outcomes with multiple neural tube defect was 55% and the remaining 30% appeared normal